DRIVE: Diabetes reversing implants with enhanced viability and long term efficacy.Proposal No: 645991.Topic: H2020- NMP-10-2014 Biomaterials for the treatment of diabetes mellitus
- Personal investigador:
- Jose Luis Pedraz, Jesus Ciriza, Rosa Hernandez, Manoli Igartua, Gorka Orive.
- Periodo:
- desde 2015 hasta 2018
- Entidad financiadora:
- European Comission
- Descripción:
-
DRIVE will develop a suite of functional biomaterials (β-Gel) for long term clinical efficacy of transplanted pancreatic islets.